Presentations Search and Views Navigation
June 18, 2020 at 11:30 AM - 12:30 PM
Opening Session: Now presented each year at the Annual Conference on Vaccinology Research, the Mary Lou Clements-Mann Memorial Lecture in Vaccine Sciences was initiated by NFID in 1999 to honor and remember a prolific, compassionate, and courageous vaccinologist.
June 18, 2020 at 12:30 PM - 1:45 PM
It is getting more difficult for some vaccines to be licensed on the basis of traditional randomized controlled trial demonstrations of efficacy against disease. This session will cover the latest thinking about clinical trial designs and approaches to demonstrate vaccine effectiveness to support licensure (including use of biomarkers predictive of protection, human challenge studies, and real word evidence).
June 18, 2020 at 2:00 PM - 3:00 PM
Vaccines were traditionally designed to mimic host immunity to infections. Increasingly, vaccines are needed that improve upon natural immunity. This session will highlight a more rational approach—inclusive of systems biology and "-omics" research—to the design and evaluation of the next generation of vaccines. Join us for this exciting panel discussion around the future of vaccinology.
June 18, 2020 at 4:00 PM - 4:15 PM
New vaccines are being developed in special populations that propose novel challenges such as immune suppression, pregnancy, and age. This session will explore approaches to solicit immune responses to vaccination in certain target populations.
June 19, 2020 at 12:00 PM - 1:00 PM
New technologies are being developed and are applied to the production of vaccines. This session will review the application of single cell analysis, next generation sequencing, and continuous manufacturing systems to the development of preventive vaccines.
June 19, 2020 at 1:00 PM - 2:15 PM
The late stage development of vaccines for global health use are challenged by complex and costly clinical studies in low-income settings and unclear financial markets. This session will describe the development strategies and partnerships that support the development of malaria, typhoid, and rotavirus vaccines.
June 19, 2020 at 2:30 PM - 3:30 PM
A number of factors including a decline in vaccination in some populations has led to resurgence of measles in the US and globally. This session will review key precipitating factors and response tactics including an examination of the recent New York City outbreak.
June 19, 2020 at 3:45 PM - 4:45 PM
Widespread vaccination efforts have led to the elimination of infectious diseases such as polio and measles in certain regions. However, eradication requires sustained and adaptable efforts to interrupt transmission in all populations and ensure pathogens are not reintroduced. To date, only one infectious disease that affects humans has been eradicated—smallpox. This session will explore various strategies used to control vaccine-preventable diseases, with the goal of elimination and, ultimately, eradication.